Showing results (181-190 of 300) with videos related to
Sort By:
Pageof 30
Biopharmaceutics & Drug Disposition|May 1, 1986
Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjectsM van der Graaff, N P Vermeulen, P Heij, et al.British Journal of Clinical Pharmacology|March 1, 1982
Differential effects of enzyme induction on antipyrine metabolite formationM Danhof, R M Verbeek, C J van Boxtel, et al.Clinical Pharmacology and Therapeutics|January 1, 1987
Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humansC H Kleinbloesem, P van Brummelen, M Danhof, et al.Brain Research|December 8, 1995
Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeabilityE C de Lange, M Danhof, C Zurcher, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatmentM W Teunissen, P H Willemse, D T Sleijfer, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1982
Zero-order rectal delivery of theophylline in man with an osmotic systemL G de Leede, A G de Boer, S L van Velzen, et al.Clinical Pharmacology and Therapeutics|December 1, 1979
Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolismA G de Boer, D D Breimer, H Mattie, et al.Anesthesiology|September 1, 1983
Plasma concentrations of lidocaine and bupivacaine after subarachnoid administrationA G Burm, J W van Kleef, M P Gladines, et al.Journal of Chromatography|December 9, 1983
Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrineM W Teunissen, J E Meerburg-van der Torren, N P Vermeulen, et al.Peptides|January 1, 1992
In vitro penetration of des-tyrosine1-D-phenylalanine3-beta-casomorphin across the blood-brain barrierH Stark, J B Van Bree, A G de Boer, et al.Pageof 30